AstraZeneca PLC (NYSE:AZN)
| 50.97 Data as of Jun 17 |  +0.17 / +0.33%Today’s Change | 41.58 Today|||52-Week Range 53.45 | +7.83% Year-to-Date |
Latest AZN News | Press Releases
| Top Treatments for High Cholesterol Jun 17 / MotleyFool.com | The Stock Picker's Guide to AstraZeneca Jun 14 / MotleyFool.com |
| Is This Purchase a Game-Changer? Jun 17 / MotleyFool.com | 5 Biotech Giants with Lucrative Dividend Yields Jun 13 / MotleyFool.com |
| AstraZeneca's MedImmune, and NGM Biopharmaceuticals Announce Agreement to Develop The... Jun 17 / Benzinga | Is Concentration Better Than Diversification in Pharma? Jun 13 / MotleyFool.com |
| AstraZeneca's Buying Spree Bolsters Pipeline Jun 14 / MotleyFool.com | Sanofi's Fluzone Quadrivalent Gets FDA Nod - Analyst Blog Jun 13 / Zacks.com |
| Strong Product Pipelines Have Pharmaceutical Companies Poised for Growth Jun 14 / MotleyFool.com | The Best Kind of Biotech Dilution Jun 12 / MotleyFool.com |
Today’s Trading
| Previous close | 50.80 |
| Today’s open | 51.19 |
| Day’s range | -- - -- |
| Volume | 1,903,883 |
| Average volume (3 months) | 2,075,144 |
| Market cap | $63.6B |
| Dividend yield | 5.49% |
Data as of 4:00pm ET, 06/17/2013
Growth & Valuation
| Earnings growth (last year) | -32.08% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -7.55% |
| Revenue growth (last year) | -16.81% |
| P/E ratio | 16.0 |
| Price/Sales | 2.13 |
| Price/Book | 2.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie Inc | -0.20 | -0.46% |
| LLYEli Lilly and Co | +0.31 | +0.60% |
| NVONovo Nordisk A/S | -5.88 | -3.51% |
| ABTAbbott Laboratories | +0.08 | +0.22% |
Data as of 4:02pm ET, 06/17/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $28.0B |
| Annual profit (last year) | $6.3B |
| Net profit margin | 22.51% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Pascal Soriot, PhD, MBA |
EVP-Global Operations & Information Services David Smith |
Corporate headquarters London, London & South East |
Forecasts
